BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3359701)

  • 1. Hemolytic uremic syndrome in childhood: renal function ten years later.
    Van Dyck M; Proesmans W; Depraetere M
    Clin Nephrol; 1988 Mar; 29(3):109-12. PubMed ID: 3359701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic uremic syndrome: defining the need for long-term follow-up.
    Small G; Watson AR; Evans JH; Gallagher J
    Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome.
    Dieguez S; Ayuso S; Brindo M; Osinde E; Cánepa C
    Nephron Clin Pract; 2004; 97(3):c118-22. PubMed ID: 15292689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemolytic-uremic syndrome in children: a 19-year retrospective study].
    Imoberdorf G; Bianchetti MG; Rossi E; Gugler E; Oetliker OH
    Schweiz Med Wochenschr; 1993 Jul; 123(29):1439-44. PubMed ID: 8367702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-hour blood pressure monitoring in children and adolescents after recovery from hemolytic uremic syndrome.
    Bald M; Lettgen B; Wingen AM; Bonzel KE
    Clin Nephrol; 1996 Jul; 46(1):50-3. PubMed ID: 8832152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic uremic syndrome: long term renal injury].
    Lumbreras Fernández J; Cruz Rojo J; Iñigo Martín G; Muley Alonso R; Vara Martín J
    An Pediatr (Barc); 2010 May; 72(5):309-16. PubMed ID: 20347408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent hemolytic-uremic syndrome: a case report.
    Drukker A; Winterborn M; Bennett B; Churg J; Spitzer A; Greifer I
    Clin Nephrol; 1975 Aug; 4(2):68-72. PubMed ID: 1157353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of childhood hemolytic-uremic syndrome with urokinase. Cooperative controlled trial].
    Loirat C; Beaufils F; Sonsino E; Schlegel N; Guesnu M; Pillion G; André JL; Broyer M; Guyot C; Habib R
    Arch Fr Pediatr; 1984 Jan; 41(1):15-9. PubMed ID: 6372729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and clinical features of hemolytic uremic syndrome].
    Nakajima M; Yoshioka A
    Nihon Rinsho; 1993 Jan; 51(1):210-4. PubMed ID: 8433521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
    Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
    Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
    Caletti MG; Gallo G
    Medicina (B Aires); 2005; 65(6):528-32. PubMed ID: 16433483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic uremic syndrome in Kuwaiti Arab children.
    Al-Eisa A; Al-Hajeri M
    Pediatr Nephrol; 2001 Dec; 16(12):1093-8. PubMed ID: 11793108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
    Zimmerhackl LB; Besbas N; Jungraithmayr T; van de Kar N; Karch H; Karpman D; Landau D; Loirat C; Proesmans W; Prüfer F; Rizzoni G; Taylor MC;
    Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolytic uremic syndrome. Evaluation of clinical and prognostic factors].
    Palomeque Rico A; Pastor Durán X; Molinero Egea C; Roca González A
    An Esp Pediatr; 1993 Nov; 39(5):391-4. PubMed ID: 8285450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
    Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
    Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.